skip to main content
Idioma:
Resultados 1 2 3 4 5 next page
Mostrar Somente
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Tumor infiltrating lymphocytes are prognostic in triple negative breast cancer and predictive for trastuzumab benefit in early breast cancer: results from the FinHER trial
Tumor infiltrating lymphocytes are prognostic in triple negative breast cancer and predictive for trastuzumab benefit in early breast cancer: results from the FinHER trial
Material Type:
Artigo 		Adicionar ao Meu Espaço

Tumor infiltrating lymphocytes are prognostic in triple negative breast cancer and predictive for trastuzumab benefit in early breast cancer: results from the FinHER trial

Loi, S. ; Michiels, S. ; Salgado, R. ; Sirtaine, N. ; Jose, V. ; Fumagalli, D. ; Kellokumpu-Lehtinen, P.-L. ; Bono, P. ; Kataja, V. ; Desmedt, C. ; Piccart, M.J. ; Loibl, S. ; Denkert, C. ; Smyth, M.J. ; Joensuu, H. ; Sotiriou, C.

Annals of oncology, 2014-08, Vol.25 (8), p.1544-1550 [Periódico revisado por pares]

Oxford: Elsevier Ltd

Texto completo disponível

Citações Citado por
2
Long-term toxic effects of adjuvant chemotherapy in breast cancer
Long-term toxic effects of adjuvant chemotherapy in breast cancer
Material Type:
Artigo 		Adicionar ao Meu Espaço

Long-term toxic effects of adjuvant chemotherapy in breast cancer

Azim, H.A. ; de Azambuja, E. ; Colozza, M. ; Bines, J. ; Piccart, M.J.

Annals of oncology, 2011-09, Vol.22 (9), p.1939-1947 [Periódico revisado por pares]

Oxford: Elsevier Ltd

Texto completo disponível

Citações Citado por
3
Proliferative markers as prognostic and predictive tools in early breast cancer: where are we now?
Proliferative markers as prognostic and predictive tools in early breast cancer: where are we now?
Material Type:
Artigo 		Adicionar ao Meu Espaço

Proliferative markers as prognostic and predictive tools in early breast cancer: where are we now?

Colozza, M. ; Azambuja, E. ; Cardoso, F. ; Sotiriou, C. ; Larsimont, D. ; Piccart, M. J.

Annals of oncology, 2005-11, Vol.16 (11), p.1723-1739 [Periódico revisado por pares]

Oxford: Oxford University Press

Texto completo disponível

Citações Citado por
4
Role of the multidisciplinary team in breast cancer management: results from a large international survey involving 39 countries
Role of the multidisciplinary team in breast cancer management: results from a large international survey involving 39 countries
Material Type:
Artigo 		Adicionar ao Meu Espaço

Role of the multidisciplinary team in breast cancer management: results from a large international survey involving 39 countries

Saini, K.S. ; Taylor, C. ; Ramirez, A.-J. ; Palmieri, C. ; Gunnarsson, U. ; Schmoll, H.J. ; Dolci, S.M. ; Ghenne, C. ; Metzger-Filho, O. ; Skrzypski, M. ; Paesmans, M. ; Ameye, L. ; Piccart-Gebhart, M.J. ; de Azambuja, E.

Annals of oncology, 2012-04, Vol.23 (4), p.853-859 [Periódico revisado por pares]

Oxford: Elsevier Ltd

Texto completo disponível

Citações Citado por
5
Comparison of HER-2 status between primary breast cancer and corresponding distant metastatic sites
Comparison of HER-2 status between primary breast cancer and corresponding distant metastatic sites
Material Type:
Artigo 		Adicionar ao Meu Espaço

Comparison of HER-2 status between primary breast cancer and corresponding distant metastatic sites

Gancberg, D. ; Di Leo, A. ; Cardoso, F. ; Rouas, G. ; Pedrocchi, M. ; Paesmans, M. ; Verhest, A. ; Bernard-Marty, C. ; Piccart, M. J. ; Larsimont, D.

Annals of oncology, 2002-07, Vol.13 (7), p.1036-1043 [Periódico revisado por pares]

Oxford: Oxford University Press

Texto completo disponível

Citações Citado por
6
Characterisation of multifocal breast cancer using the 70-gene signature in clinical low-risk patients enrolled in the EORTC 10041/BIG 03-04 MINDACT trial
Characterisation of multifocal breast cancer using the 70-gene signature in clinical low-risk patients enrolled in the EORTC 10041/BIG 03-04 MINDACT trial
Material Type:
Artigo 		Adicionar ao Meu Espaço

Characterisation of multifocal breast cancer using the 70-gene signature in clinical low-risk patients enrolled in the EORTC 10041/BIG 03-04 MINDACT trial

Aalders, K.C ; Kuijer, A ; Straver, M.E ; Slaets, L ; Litiere, S ; Viale, G ; van't Veer, L.J ; Glas, A.M ; Delorenzi, M ; van Dalen, T ; Tryfonidis, K ; Piccart, M.J ; Cardoso, F ; Rutgers, E.J

European journal of cancer (1990), 2017-07, Vol.79, p.98-105 [Periódico revisado por pares]

England: Elsevier Ltd

Texto completo disponível

Citações Citado por
7
Correction to: 3rd ESO–ESMO International Consensus Guidelines for Advanced Breast Cancer (ABC 3)
Correction to: 3rd ESO–ESMO International Consensus Guidelines for Advanced Breast Cancer (ABC 3)
Material Type:
Artigo 		Adicionar ao Meu Espaço

Correction to: 3rd ESO–ESMO International Consensus Guidelines for Advanced Breast Cancer (ABC 3)

Cardoso, F. ; Costa, A. ; Senkus, E. ; Aapro, M. ; André, F. ; Barrios, C.H. ; Bergh, J. ; Bhattacharyya, G. ; Biganzoli, L. ; Cardoso, M.J. ; Carey, L. ; Corneliussen-James, D. ; Curigliano, G. ; Dieras, V. ; El Saghir, N. ; Eniu, A. ; Fallowfield, L. ; Fenech, D. ; Francis, P. ; Gelmon, K. ; Gennari, A. ; Harbeck, N. ; Hudis, C. ; Kaufman, B. ; Krop, I. ; Mayer, M. ; Meijer, H. ; Mertz, S. ; Ohno, S. ; Pagani, O. ; Papadopoulos, E. ; Peccatori, F. ; Penault-Llorca, F. ; Piccart, M.J. ; Pierga, J.Y. ; Rugo, H. ; Shockney, L. ; Sledge, G. ; Swain, S. ; Thomssen, C. ; Tutt, A. ; Vorobiof, D. ; Xu, B. ; Norton, L. ; Winer, E.

Annals of oncology, 2017-12, Vol.28 (12), p.3111-3111 [Periódico revisado por pares]

Elsevier Ltd

Texto completo disponível

Citações Citado por
8
A standardised, generic, validated approach to stratify the magnitude of clinical benefit that can be anticipated from anti-cancer therapies: the European Society for Medical Oncology Magnitude of Clinical Benefit Scale (ESMO-MCBS)
A standardised, generic, validated approach to stratify the magnitude of clinical benefit that can be anticipated from anti-cancer therapies: the European Society for Medical Oncology Magnitude of Clinical Benefit Scale (ESMO-MCBS)
Material Type:
Artigo 		Adicionar ao Meu Espaço

A standardised, generic, validated approach to stratify the magnitude of clinical benefit that can be anticipated from anti-cancer therapies: the European Society for Medical Oncology Magnitude of Clinical Benefit Scale (ESMO-MCBS)

Cherny, N.I. ; Sullivan, R. ; Dafni, U. ; Kerst, J.M. ; Sobrero, A. ; Zielinski, C. ; de Vries, E.G.E. ; Piccart, M.J.

Annals of oncology, 2015-08, Vol.26 (8), p.1547-1573 [Periódico revisado por pares]

England: Elsevier Ltd

Texto completo disponível

Citações Citado por
9
ESMO-Magnitude of Clinical Benefit Scale version 1.1
ESMO-Magnitude of Clinical Benefit Scale version 1.1
Material Type:
Artigo 		Adicionar ao Meu Espaço

ESMO-Magnitude of Clinical Benefit Scale version 1.1

Cherny, N.I. ; Dafni, U. ; Bogaerts, J. ; Latino, N.J. ; Pentheroudakis, G. ; Douillard, J.-Y. ; Tabernero, J. ; Zielinski, C. ; Piccart, M.J. ; de Vries, E.G.E.

Annals of oncology, 2017-10, Vol.28 (10), p.2340-2366 [Periódico revisado por pares]

England: Elsevier Ltd

Texto completo disponível

Citações Citado por
10
3rd ESO–ESMO International Consensus Guidelines for Advanced Breast Cancer (ABC 3)
3rd ESO–ESMO International Consensus Guidelines for Advanced Breast Cancer (ABC 3)
Material Type:
Artigo 		Adicionar ao Meu Espaço

3rd ESO–ESMO International Consensus Guidelines for Advanced Breast Cancer (ABC 3)

Cardoso, F. ; Costa, A. ; Senkus, E. ; Aapro, M. ; André, F. ; Barrios, C.H. ; Bergh, J. ; Bhattacharyya, G. ; Biganzoli, L. ; Cardoso, M.J. ; Carey, L. ; Corneliussen-James, D. ; Curigliano, G. ; Dieras, V. ; El Saghir, N. ; Eniu, A. ; Fallowfield, L. ; Fenech, D. ; Francis, P. ; Gelmon, K. ; Gennari, A. ; Harbeck, N. ; Hudis, C. ; Kaufman, B. ; Krop, I. ; Mayer, M. ; Meijer, H. ; Mertz, S. ; Ohno, S. ; Pagani, O. ; Papadopoulos, E. ; Peccatori, F. ; Penault-Llorca, F. ; Piccart, M.J. ; Pierga, J.Y. ; Rugo, H. ; Shockney, L. ; Sledge, G. ; Swain, S. ; Thomssen, C. ; Tutt, A. ; Vorobiof, D. ; Xu, B. ; Norton, L. ; Winer, E.

Annals of oncology, 2017-01, Vol.28 (1), p.16-33 [Periódico revisado por pares]

England: Elsevier Ltd

Texto completo disponível

Citações Citado por
Resultados 1 2 3 4 5 next page

Personalize Seus Resultados

  1. Editar

Refine Search Results

Expandir Meus Resultados

  1.   

Mostrar Somente

  1. Revistas revisadas por pares (121)

Data de Publicação 

De até
Refinar
  1. Antes de1996  (15)
  2. 1996Até2001  (37)
  3. 2002Até2007  (38)
  4. 2008Até2015  (17)
  5. Após 2015  (18)
  6. Mais opções open sub menu

  • Realização: ABCD-USP USP   Logos de Redes Sociais: Freepik

Buscando em bases de dados remotas. Favor aguardar.